z-logo
open-access-imgOpen Access
Arterial and Antihypertensive Effects of Nitrendipine: A Double-Blind Comparison Versus Placebo
Author(s) -
Roland Asmar,
Athanase Bénétos,
M. Brahimi,
Kamel Chaouche,
Michel Safar
Publication year - 1992
Publication title -
journal of cardiovascular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/00005344-199212000-00002
Subject(s) - nitrendipine , medicine , pulse wave velocity , blood pressure , placebo , ambulatory , ambulatory blood pressure , diastole , anesthesia , cardiology , alternative medicine , pathology
Arterial effects evaluated by carotid-femoral, brachial-radial, and femoral-tibial pulse wave velocity and antihypertensive effect evaluated by 24-h ambulatory blood pressure (BP) monitoring were measured in 17 hypertensive patients before and 24 h after once-daily nitrendipine (20 mg) administration. After a 15-day placebo period, a double-blind study of nitrendipine versus placebo was performed for 1 month. After nitrendipine dosing, BP measured by sphygmomanometer 24 h after the last drug intake showed a significant decrease as compared with the pretreatment period. Ambulatory BP mean values were also significantly decreased for systolic and diastolic BP (SBP, DBP). This decrease predominated during the day but was observed nocturnally only after 6 a.m. Twenty-four hours after the last tablet intake of nitrendipine, carotid-femoral and brachial-radial pulse wave velocities were significantly reduced, whereas femoral-tibial wave velocity was unchanged, indicating that markers of arterial rigidity might be substantially modified and that the modifications were partly unrelated to BP changes. The results provide evidence that in hypertensive subjects nitrendipine 20 mg given once daily for 1 month produces an arterial effect for 24 h, in association with BP reduction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here